Who We Fund
Since 1949, 探花视频 has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who鈥檝e joined our fight to find cures and help blood cancer patients everywhere.
Carl June
CAR T immunotherapy
Courtney DiNardo
clinical trials, AML
Jenny Wang
AML
Madhav Dhodapkar
multiple myeloma immunotherapy
Adam de Smith
pediatric ALL and Down Syndrome
Noem铆 Puig Mor贸n
Myeloma
Marina Konopleva
MDS/AML metabolism
Adi Nagler
Bronchiolitis obliterans after transplant
Paolo Strati
Non-Hodgkin Lymphoma
Soheil Meshinchi
pediatric AML
Yubin Zhou
peripheral T cell lymphoma
Tycel Phillips
Mantle Cell Lymphoma
Sigur冒ur Kristinsson
Smoldering myeloma
Bingyi Chen
AML immunotherapy
Yoke Seng Lee
AML
Fahmin Basher
transplant and GvHD
Ravi Bhatia
transplantation
Bailee Kain
AML and African ancestry
Pooja Khandelwal
bone marrow transplantation
Riccardo Dalla-Favera
lymphoma (DLBCL)
Ricky Johnstone
lymphoma and myeloma
Matthew Frank
Lymphoma CART therapy
Enterome
vaccine, FL, MZL
Sergei Doulatov
Leukemias
Armin Rashidi
gut bacteria and transplant success
Roberta Zappasodi
lymphoma, immunotherapy
Liran Shlush
pre-leukemia
Brian Walker
smoldering myeloma, MGUS
Takeshi Sugio
T-cell lymphoma
Sham Mailankody
Myeloma immunotherapy clinical trials
Ari Melnick
epigenetics and lymphoma
Tak Mak
Immunotherapy
Christopher Flowers
clinical trial access
Amit Verma
AML/MDS
Christian Marinaccio
MLL leukemias
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Constellation Pharmaceuticals
myeloproliferative neoplasms
Piers Patten
COVID-19
Urvi Shah
Diet and myeloma
Rachel Mersfelder
AMKL
Alex Kentsis
pediatric leukemias
Matteo Bellone
Smoldering multiple myeloma
Yan Liu
MDS
Lori Muffly
Equity in Access
Inhye Ahn
CLL
Solu Therapeutics
immunotherapy, CMML
Coleman Lindsley
AML/MDS
Koichi Takahashi
AML/MDS
Jeffrey Magee
pediatric AML
Peter Croucher
Multiple Myeloma
Jing Fu
myeloma
Caroline Arber
myeloma CAR-T
BioInvent International
immunotherapy, indolent NHL, CTCL
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Qing Yi
Novel CAR-T
Jonathan Licht
DNA biology, myeloma
Gianpietro Dotti
CAR T and AML
Daniel Thomas
Myelofibrosis
Kathleen Sakamoto
pediatric AML
Ruben Carrasco
Myeloma
Catherine Bollard
pediatric blood cancers and immunotherapy
Neha Mehta-Shah
T-cell lymphoma
George Vassiliou
Leukemia Prevention
Meng Li
Equity in Access
Mark Hamilton
DLBCL and CAR-T
Rizwan Romee
Immunotherapy
Catherine Diefenbach
DLBCL immunology
Steven Park
follicular lymphoma
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Michael Wang
Mantle Cell Lymphoma
Sahand Hormoz
MPN
Christine Zhang
AML
Affimed
immunotherapy, HL, PTCL
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Oreofe Odejide
Equity in Access
Mark Murakami
follicular lymphoma
Mendel Goldfinger
MDS/AML trials for the elderly
Jennifer Woyach
CLL trials
Andrew Lane
BPDCN
Keisuke Ito
blood cancer stem cells and MDS metabolism
Christopher Booth
BPDCN
Brian Dalton
DNA mutations and myeloid cancers
Jalpa Doshi
Equity in Access
Michaela Reagan
Multiple Myeloma
Faron Pharmaceuticals
immunotherapy, MDS
Jianguo Tao
Mantle Cell Lymphoma
Suzanne Lentzsch
Myeloma
Shazia Nakhoda
Equity in Access
Tomasz Skorski
myeloproliferative neoplasms, AML
Rgenta Therapeutics
RNA-targeting, blood cancer
Jayna Mistry
aging and leukemias
Alfred Garfall
myeloma immunotherapy
Marc Seifert
Hairy cell leukemia
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Steven Horwitz
T-cell lymphomas
Catriona Jamieson
cancer stem cell biology
Rajni Kumari
AML
Pietro Genovese
transplant and AML
Shannon Maude
Immunotherapy for ALL
Thomas LeBlanc
palliative care
Julia Maxson
AML
Paola Aguilar Neuville
Primary cutaneous 纬未 T-cell lymphoma
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Alieen Rowan
Adult T cell leukemia/lymphoma
Nataly Cruz-Rodriguez
T-ALL and metabolism
Jolanta Grembecka
leukemia therapeutics
Steven Treon
Lymphomas and Waldenstrom's
Robert Soiffer
transplantation
Timothy Graubert
AML and MDS biology
Ronald Levy
immunotherapies, COVID-19
Jing Yang
Myeloma
Jaehyuk Choi
T-cell lymphoma
John Crispino
myelofibrosis, pediatric leukemia and Downs
Tyler Parsons
MPN and AML
Daniel Pollyea
AML
John Leonard
lymphoma research
Paul Beavis
immunotherapy in myeloma
Jonathon Cohen
lymphoma clinical trial access in Georgia
Jean Koff
Disparities in DLBCL
Anthony Letai
improving CAR-T
Catherine Smith
leukemia
Michael Keller
COVID-19, immunotherapy
Xu Ji
Equity in Access
Wendy Stock
T-cell ALL
Suman Paul
T cell cancers and immunotherapy
Robert Orlowski
(Smoldering) Multiple Myeloma
John DiPersio
trispecific antibody for AML and MDS
Daniel Herranz
T-ALL
Logan Spector
childhood leukemia epidimiology
Nizar Bahlis
Myeloma immunotherapy
Bruno Paiva
smoldering myeloma
Philippe Armand
follicular lymphoma
Nitin Jain
CLL
Cailin Collins
Leukemia and pre-leukemia
Lev Kats
myeloma and epigenetics
Margaret Shipp
lymphoma biology
Helen Parsons
Equity in Access
Jeremy Baeten
AML
Stephen Nimer
myeloid cancer biology
Qingyu Luo
BPDCN
Sriram Sundaravel
AML stem cells
Rong Lu
preleukemia, leukemia
Craig Jordan
AML
Martin Dreyling
Mantle Cell Lymphoma
Lucy Godley
preleukemia
Britta Will
Leukemia and pre-leukemia
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Caron Jacobson
lymphoma and immunotherapy
Nirav Shah
CAR-T for lymphoma
Sarah Tasian
pediatric leukemias
Simona Colla
Myeloma biology
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Carma Bylund
Equity in Access
Markus Muschen
leukemia and lymphoma biology
Jeetayu Biswas
splicing in myeloid diseases
Trent Hall
MDS
Maximilian Stahl
AML immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Kerry Rogers
CLL
Eugenio Morelli
Myeloma
Stephen Gottschalk
pediatric leukemia and CAR-T
William Matsui
Myeloma
Mala Shanmugam
myeloma
Richard Lock
T-ALL
Hong Wen
AML
Yibin Yang
Lymphoma
Teresa Palomero
Peripheral T-cell Lymphoma
Mark Dawson
B-ALL and CAR-T resistance
Elliot Stieglitz
CMML
Jake Shortt
precision therapy for aggressive lymphomas
Dan Landau
cancer evolution biology
Huda Salman
CMML
Eric Padron
CMML
Marco Ruella
Immunotherapy for T-cell lymphoma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
F. Lennie Wong
Equity in Access
Saar Gill
AML immunotherapy
James Rubenstein
Lymphoma of the Central Nervous System
Tanya Siddiqi
clinical trial access
Eric Pietras
AML
Grzegorz Nowakowski
Clinical trial access
Ravindra Majeti
preleukemia, AML
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Courtney Jones
AML metabolism
Luca Busino
DLBCL
Leandro Cerchietti
DLBCL
Omar Abdel-Wahab
Hairy cell leukemia
Kimberly Stegmaier
childhood blood cancers
ImCheck Therapeutics
immunotherapy, AML
Enrico Tiacci
Hairy cell leukemia
Alexey Danilov
lymphoma
Fenghuang Zhan
Myeloma and bone disease
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Liling Wan
AML
Michael Savona
MDS and leukemia
Manyi Wei
acute megakaryoblastic leukemia
Kura Oncology
MLL leukemia, AML
Kasey Leger
pediatric blood cancers
Siegfried Janz
Myeloma immunotherapy
Jun Qi
Myeloma
Justine Kahn
pediatric leukemia and lymphoma
Peter Klein
MDS
Nicoletta Cieri
AML and transplantation
Caner Saygin
T-ALL
Sheng Li
Aging and AML
Julia Paczkowska
immunobiology of Hodgkin's disease
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Jianhua Yu
myeloma immunotherapy
Dane Vassiliadis
blood cancer biology
Paolo Caimi
CAR-T clinical trial for CLL
Srividya Swaminathan
pediatric, immunotherapy
Adam Olszewski
Follicular and marginal zone lymphoma
Frederick Locke
lymphoma and immunotherapy
Daniel Lucas
bone marrow and leukemia biology
Grant Challen
preleukemia, leukemia
Stacie Dusetzina
Equity in Access
Thomas Koehnke
leukemia
Eirini Papapetrou
blood cancer stem cells
Raymond Mailhot
Equity in Access
Wendy B茅guelin
follicular lymphoma
Thomas Kipps
Hairy Cell Leukemia
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Ann-Kathrin Eisfeld
Racial diversity in AML
Jennifer Amengual
lymphomas after transplant
Jennifer Trowbridge
aging and leukemia
Yiman Liu
Epigenetics and leukemia
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Venkata Lokesh Battula
immunotherapy and AML
Siddhartha Jaiswal
preleukemia
Christian Steidl
B-cell lymphomas
Carl Allen
pediatric blood cancers
H. Irene Su
Equity in Access
Lawrence Boise
CART and myeloma
Taishi Yonezawa
AML
Nicolas Nassar
pediatric leukemia
Anouchka Laurent
T-cell lymphoma
Daisuke Nakada
preleukemia, leukemia
Anushree Vichare
Equity in Access
Joachim Yahalom
Lymphoma
Kirk Schultz
pediatric transplantation
Bing Carter
p53 mutant AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Roland Walter
Antibody-based AML therapies
Ana Vujovic
AML
Michael Green
lymphoma biology
Reina Takeda
AML
Lindsey Montefiori
pediatric leukemia
Megan McNerney
AML/MDS
Randall Davis
CLL
Dimericon Therapeutics
dimericons, blood cancer
Jonas Jutzi
myeloproliferative neoplasms
Nicola Vannini
Aging and CAR-T success
Hao Jiang
DNA biology and leukemia
Christopher Porter
Leukemia, lymphoma
Jessica Stewart
Epstein-barr virus and lymphomas
Gaurav Goyal
Erdheim-Chester Disease
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Michael Kharas
leukemia
Sam Butterworth
CMML